Novo Nordisk A/S

A world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. Novo A/S, the holding company of the Novo Group, is fully owned by the Novo Nordisk Foundation and was established to manage the Foundation's funds and to invest actively in other companies.

Activity:

- Manufacturing
- Market Research & Marketing

Product / Technology type(s) covered:

- Bio
- Enzymes
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Diabetes

Markets Covered

a. HeadQuarter: Denmark

b. Continent(s) active: Europe , North America , Asia , Africa , South America , Near/Middle East , Far East

c. Countries active:

Corporate data:

Number of Employees: 27

Turnover:

Amount:	Year:	Currency:
3625000	2001	Euro

Year founded: 1999